HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ester Simeone Selected Research
Ester Simeone Research Topics
Disease
69
Melanoma (Melanoma, Malignant)
11/2023 - 03/2005
23
Neoplasms (Cancer)
11/2023 - 03/2005
11
Disease Progression
01/2022 - 11/2006
7
Neoplasm Metastasis (Metastasis)
11/2016 - 03/2005
6
Brain Neoplasms (Brain Tumor)
01/2023 - 03/2005
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 08/2015
1
Type 2 Diabetes Mellitus (MODY)
10/2023
1
Inflammation (Inflammations)
01/2023
1
COVID-19
10/2020
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020
1
Keratoacanthoma
08/2015
1
Lymphadenopathy
04/2015
1
Febrile Neutropenia
07/2014
1
Leukopenia
07/2014
1
Neutropenia
07/2014
1
Non-Muscle Invasive Bladder Neoplasms
04/2010
1
Nevus (Nevi)
11/2005
1
Fatigue
03/2005
1
Nausea
03/2005
1
Vomiting
03/2005
Drug/Important Bio-Agent (IBA)
22
Ipilimumab
IBA
01/2023 - 05/2012
13
Vemurafenib
IBA
01/2021 - 05/2012
9
Immune Checkpoint Inhibitors
IBA
10/2023 - 01/2014
9
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022 - 07/2012
8
Nivolumab
IBA
11/2023 - 02/2015
8
Biomarkers (Surrogate Marker)
IBA
11/2023 - 11/2006
8
dabrafenib
IBA
12/2017 - 05/2012
6
Antibodies
IBA
12/2017 - 10/2010
5
pembrolizumab
IBA
01/2022 - 02/2015
5
cobimetinib
IBA
01/2021 - 07/2012
5
Interferons
IBA
01/2021 - 09/2012
5
Monoclonal Antibodies
IBA
02/2015 - 07/2012
4
trametinib
IBA
12/2017 - 03/2014
4
Bleomycin (Blenoxane)
FDA Link
Generic
01/2017 - 12/2013
3
fotemustine (Muphoran)
IBA
02/2018 - 09/2012
3
Dacarbazine (DIC)
FDA Link
Generic
06/2015 - 02/2013
2
durvalumab
IBA
12/2017 - 01/2017
2
atezolizumab
IBA
12/2017 - 01/2017
2
Mitogen-Activated Protein Kinases
IBA
12/2017 - 02/2017
2
Cytokines
IBA
01/2017 - 07/2016
2
Lactate Dehydrogenase 5
IBA
11/2016 - 05/2012
2
Interferon-alpha (Interferon Alfa)
IBA
08/2014 - 08/2010
2
Temozolomide (Temodar)
FDA Link
Generic
05/2013 - 03/2005
2
Antigens
IBA
07/2012 - 10/2010
2
Ligands
IBA
07/2012 - 03/2005
2
Enzymes
IBA
02/2006 - 10/2005
1
relatlimab
IBA
10/2023
1
Conditioned Culture Media
IBA
10/2023
1
Peroxidase (Myeloperoxidase)
IBA
10/2023
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
10/2023
1
Interleukin-6 (Interleukin 6)
IBA
01/2023
1
cemiplimab
IBA
01/2023
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2023
1
Adenosine (Adenocard)
FDA Link
Generic
01/2022
1
Cetirizine (Zyrtec)
FDA Link
Generic
01/2022
1
MicroRNAs (MicroRNA)
IBA
01/2022
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
03/2021
1
Volatile Fatty Acids
IBA
01/2020
1
Butyrates (Butyrate)
IBA
01/2020
1
binimetinib
IBA
12/2017
1
avelumab
IBA
01/2017
1
Interleukin-15 (Interleukin 15)
IBA
01/2017
1
Histocompatibility Antigens Class I
IBA
07/2016
1
Peptides (Polypeptides)
IBA
07/2016
1
Immunophilins
IBA
07/2015
1
Protein Isoforms (Isoforms)
IBA
07/2015
1
Anti-Bacterial Agents (Antibiotics)
IBA
07/2014
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
07/2014
1
Cell-Free Nucleic Acids
IBA
09/2013
1
keyhole-limpet hemocyanin (keyhole limpet hemocyanin)
IBA
05/2013
1
Vaccines
IBA
07/2012
1
Autoantibodies
IBA
08/2010
1
Interleukins
IBA
08/2010
1
Transforming Growth Factor beta (TGF-beta)
IBA
08/2010
1
Interleukin-10 (Interleukin 10)
IBA
08/2010
1
Gemcitabine
FDA Link
04/2010
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
11/2006
1
plerixafor
FDA Link
04/2006
1
Chemokine Receptors
IBA
04/2006
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
02/2006
1
Complement System Proteins (Complement)
IBA
11/2005
1
Polyethylene Glycols (Polyethylene Glycol)
FDA Link
Generic
10/2005
1
arginine deiminase
IBA
10/2005
1
Arginine (L-Arginine)
FDA Link
10/2005
1
Essential Amino Acids
IBA
10/2005
1
Amino Acids
FDA Link
10/2005
1
ADI PEG20
IBA
10/2005
1
methoxypolyethylene glycol succinimidylsuccinate
IBA
10/2005
1
Cisplatin (Platino)
FDA Link
Generic
03/2005
1
Proteins (Proteins, Gene)
FDA Link
03/2005
Therapy/Procedure
26
Therapeutics
11/2023 - 03/2005
19
Immunotherapy
01/2023 - 05/2013
4
Drug Therapy (Chemotherapy)
01/2022 - 05/2012
4
Radiotherapy
04/2021 - 05/2012
3
Intravenous Injections
01/2017 - 12/2013
1
Operative Surgical Procedures
01/2017
1
Aftercare (After-Treatment)
07/2014
1
Blood Transfusion (Blood Transfusions)
07/2014
1
Retreatment
05/2014
1
Cystectomy
04/2010